#puberty-blockers

#puberty-blockers

Transgender youth, supported by their families, require access to gender-affirming care for their mental well-being.

The debate on puberty blockers in gender-care is exaggerated; evidence for their effectiveness in most young individuals is limited.

The UK has enacted an indefinite ban on puberty blockers for transgender youth, raising significant concerns regarding safety and evidence of effectiveness.

Elon Musk expressed regret over allowing his trans child to take puberty blockers, linking it to 'woke mind virus'.

Musk's condemnation of puberty blockers contrasts with his daughter's advocacy for trans youth and their treatment options.

Northern Ireland has indefinitely banned puberty blockers for transgender minors, citing the protection and safety of young people as the primary concern.

The UK is indefinitely banning puberty blockers for under-18s with gender dysphoria, except in clinical trials, due to safety concerns.

Permanent ban on puberty blockers for under-18s announced due to safety concerns and lack of evidence regarding treatment effectiveness.

The UK has indefinitely banned puberty blockers for under 18s experiencing gender dysphoria due to safety concerns.

UK government bans new private puberty blocker prescriptions for under-18s.

Dr. Hilary Cass reviewed England's gender distress guidelines, finding weak evidence for puberty blockers in adolescents, cautioning on testosterone/estrogen use.

JK Rowling claimed nature is the best cure for gender dysphoria, criticizing gender-affirming care for trans youth.

The British Medical Association is evaluating the Cass Review's recommendations regarding puberty blockers for youngsters.

Puberty blockers for under-18s with gender dysphoria will be banned indefinitely in the UK, except in clinical trials.

Senior doctors disappointed with BMA stance on gender services, calling for reforms to be reevaluated.

A review of gender services exposed lack of research and weak evidence, prompting a shift to broader mental health-focused support.

Puberty blockers remain crucial for trans youth healthcare despite claims made by Dr. Hilary Cass.